Mayo D R, Sirpenski S P, Markowski M
Diagn Microbiol Infect Dis. 1986 May;5(1):55-9. doi: 10.1016/0732-8893(86)90091-x.
Sera were tested for rubella antibody by a standard hemagglutination inhibition method and by latex agglutination in microtiter plates (Virogen Rubella Micro Test). When 157 sera were examined by hemagglutination inhibition and by microtiter latex agglutination for immune status, 149 of the results agreed. The eight discrepant sera (all hemagglutination inhibition-negative, latex agglutination-positive) were tested by a card latex agglutination method (Rubascan) and a passive hemagglutination method (Rubacell). Results, except where noted, agreed with those of the microtiter latex agglutination. One hundred forty-eight of the 149 sera that were in agreement as to immune status were also within a fourfold variation when hemagglutination inhibition and latex agglutination titers were compared. An additional 100 sera were tested for immune status by microtiter latex agglutination and by passive hemagglutination with the single discrepant result agreeing with the latex agglutination when tested by a third method. Both microtiter latex agglutination and hemagglutination inhibition agreed in detection of fourfold or greater rises in each of 20 paired sera.
采用标准血凝抑制法及微量滴定板乳胶凝集法(Virogen风疹微量检测法)检测血清中的风疹抗体。对157份血清进行血凝抑制检测及微量滴定板乳胶凝集检测以确定免疫状态时,149份血清的检测结果一致。对8份结果不一致的血清(所有血凝抑制检测为阴性、乳胶凝集检测为阳性)采用卡片乳胶凝集法(Rubascan)及被动血凝法(Rubacell)进行检测。除另有说明外,结果与微量滴定板乳胶凝集检测结果一致。在149份免疫状态检测结果一致的血清中,当比较血凝抑制效价及乳胶凝集效价时,148份血清的效价差异在4倍以内。另外对100份血清进行微量滴定板乳胶凝集检测及被动血凝检测以确定免疫状态,唯一不一致的结果在采用第三种方法检测时与乳胶凝集检测结果一致。在检测20对配对血清中每对血清效价是否有4倍或更高的升高时,微量滴定板乳胶凝集检测及血凝抑制检测结果均一致。